Kveim test

From WikiMD's WELLNESSPEDIA

Kveim test is a skin test used in the diagnosis of sarcoidosis, a disease involving abnormal collections of inflammatory cells that form lumps known as granulomas. The test involves the injection of a preparation of sarcoid tissue into the skin of a person suspected of having the disease. If granulomas similar to those found in sarcoidosis form at the site of injection, the test is considered positive.

History[edit]

The Kveim test was first described in 1941 by the Norwegian pathologist Morten Ansgar Kveim. The test was widely used in the 1960s and 1970s, but its use has declined due to concerns about the safety of the test material and the development of more accurate diagnostic methods.

Procedure[edit]

The Kveim test involves injecting a small amount of a preparation made from the spleen or lymph nodes of a person with sarcoidosis into the skin of the person being tested. The test is usually performed on the forearm. If the person being tested has sarcoidosis, a granuloma will usually form at the site of injection within 4 to 6 weeks.

Accuracy[edit]

The Kveim test is not 100% accurate. False positives can occur if the person being tested has another disease that can cause granulomas to form, such as tuberculosis or leprosy. False negatives can occur if the person being tested has a weak immune response.

Safety[edit]

The safety of the Kveim test has been a concern because the test material is made from human tissue, which could potentially transmit infectious diseases. However, no cases of disease transmission have been reported.

Alternatives[edit]

The Kveim test is not commonly used today because more accurate and safer methods of diagnosing sarcoidosis are available. These include blood tests, imaging studies such as X-rays and CT scans, and biopsy of affected tissues.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.